-
Sulfo-NHS-LC-Biotin: Practical Labeling Guide
2026-09-22
Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of accessible primary amines on proteins, peptides, and intact cell surfaces. It is suited to extracellular detection, capture, and immobilization workflows, but not to intracellular labeling or applications requiring reversible modification.
-
CGK733 and Ferroptosis in TP53-Mutant GBM
2026-09-22
A translational framework for testing whether CGK733 can connect DNA-damage response signaling with the iron and ferroptosis vulnerabilities revealed in TP53-mutant glioblastoma.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-09-21
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended for high-resolution protein electrophoresis and peptide separation in the low-molecular-weight range, including targets near 1.2 kDa. It is suitable for research denaturing or non-denaturing workflows when sample and running conditions are compatible, but it is not intended for diagnostic, clinical, or medical use.
-
Rucaparib in DNA Damage Response Workflows
2026-09-21
Use Rucaparib to connect PARP1 inhibition with measurable DNA-break persistence, radiosensitization, and repair-pathway vulnerability. This workflow-focused guide combines compound handling, foci imaging, transporter-aware controls, and Pol II-informed assay design for more interpretable cancer biology research.
-
NU7441 (KU-57788) DNA-PK Inhibition Workflows
2026-09-20
NU7441 (KU-57788) gives researchers a selective way to test DNA-PK-dependent repair, damage sensitization, and cell-cycle effects. This practical guide connects biochemical selectivity with reproducible in vitro, in vivo, and translational assay design.
-
LY294002: A Mechanism-First Assay Guide
2026-09-19
LY294002 offers a reversible, cell-permeable route to interrogate class I PI3K signaling. This mechanism-first guide connects pathway pharmacology with macrophage-polarization assays, autophagy studies, apoptosis analysis, and translational interpretation.
-
Olaparib as a Metabolic DNA-Repair Probe
2026-09-18
Olaparib and AZD2281 can do more than model BRCA-associated repair defects. This guide explains how to pair PARP inhibition with metabolic and chromatin measurements to reveal αKG-dependent mechanisms of homologous recombination proficiency and improve DNA damage response assay design.
-
PDK4-IN-1 Hydrochloride Workflow Guide
2026-09-18
Build reproducible PDK4 inhibition experiments around PDH activation, mitochondrial energy metabolism modulation, and downstream glycolysis–TCA cycle readouts. This practical guide separates reference-backed findings from starting conditions for metabolic, cardiac, and tumor models.
-
Isochlorogenic Acid A Hydrogel for Wound Repair
2026-09-17
A 2026 Gels study developed amylopectin/carboxymethyl chitosan dressings containing Isochlorogenic acid A/Fe(III) co-assembled nanoparticles to address the compound’s poor water solubility and limited structural stability. The composite showed antibacterial activity, favorable mechanical and self-healing properties, enhanced cell migration, and improved wound repair-associated readouts in preclinical testing.
-
Fasudil (HA-1077) HCl for ROCK Assays
2026-09-17
Fasudil (HA-1077) HCl provides a practical ROCK inhibitor workflow for separating changes in proliferation, migration, apoptosis, and pathway activity. This guide adapts the reference study’s multi-endpoint design to cancer, lens-cell, and hematological research while emphasizing controls, dosing logic, and troubleshooting.
-
CD80 and 4-1BBL mRNA T-Cell Vaccines
2026-09-16
Cho et al. investigated expanded CD4 T cells engineered with CD80 mRNA, 4-1BBL mRNA, or both as an alternative cellular cancer-vaccine platform. The combined costimulatory design produced stronger CD8 T-cell proliferation, cytotoxicity, memory responses, and antitumor activity than either single-ligand approach in the reported models.
-
KU-60019: ATM Kinase Inhibitor Workflow
2026-09-16
Build reproducible glioma radiosensitization, DNA-repair, and migration assays with KU-60019, a selective ATM kinase inhibitor. This guide connects mechanism-driven controls with practical dosing, formulation, readout, and troubleshooting strategies for in vitro and exploratory in vivo research.
-
Deferiprone as a Tool for Iron-Stress Phenotyping
2026-09-15
Deferiprone enables controlled investigation of iron-stress phenotypes across metabolic, inflammatory, and tumor models. This article translates enterocyte metabolomics findings into a practical framework for choosing doses, controls, readouts, and cross-domain applications.
-
Hexetidine Mouthwash: A Systematic Review
2026-09-15
The reference study systematically evaluated hexetidine mouthwash for plaque control and gingival inflammation, narrowing 168 records to six eligible publications. Its descriptive comparison suggests that, despite antimicrobial activity, Hexetidine was not a convincing alternative to chlorhexidine when benefits and observed adverse effects were considered.
-
Fyn–Stat3 Signaling in Zebrafish Neurodegeneration
2026-09-14
This 2024 study identifies Stat3 as a downstream effector linking activated Fyn kinase to dopaminergic neuron loss and microglia activation in zebrafish. Its combination of cell-type-specific genetics, live imaging, transcriptomics, and pathway inhibition provides a useful framework for distinguishing Fyn-driven neurodegeneration from associated inflammatory responses.